Cytokinetics
CYTK
#2216
Rank
โ‚น840.55 B
Marketcap
โ‚น6,046
Share price
-4.42%
Change (1 day)
12.38%
Change (1 year)

Market capitalization of Cytokinetics (CYTK)

Market cap: โ‚น840.55 Billion

As of October 2026 Cytokinetics has a market cap of โ‚น840.55 Billion. This makes Cytokinetics the world's 2216th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cytokinetics from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น840.55 B21.35%
2025โ‚น692.67 B44.47%
2024โ‚น479.47 B-29.65%
2023โ‚น681.51 B89.94%
2022โ‚น358.80 B25.32%
2021โ‚น286.31 B166.18%
2020โ‚น107.56 B140.26%
2019โ‚น44.77 B85.15%
2018โ‚น24.18 B-13.77%
2017โ‚น28.04 B-16.38%
2016โ‚น33.53 B21.88%
2015โ‚น27.51 B40.19%
2014โ‚น19.62 B59.29%
2013โ‚น12.32 B139.33%
2012โ‚น5.14 B40.25%
2011โ‚น3.67 B-41.42%
2010โ‚น6.26 B-24.26%
2009โ‚น8.27 B20.94%
2008โ‚น6.84 B-25.22%
2007โ‚น9.14 B-36.2%
2006โ‚น14.33 B81.5%
2005โ‚น7.90 B-33.7%
2004โ‚น11.91 B

End of Day market cap according to different sources

On Oct 5th, 2026 the market cap of Cytokinetics was reported to be:

โ‚น840.55 Billion
by Nasdaq info icon info icon
โ‚น840.55 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
โ‚น21.008 T 2,399.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
โ‚น0.99 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น589.73 B-29.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
โ‚น79.17 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
โ‚น57.91 B-93.11%๐Ÿ‡บ๐Ÿ‡ธ USA